The healthcare hardware market is on the brink of a monumental leap, projected to skyrocket to $464.45 billion by 2034.
Last week, QuidelOrtho Corporation QDEL announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the ...
Nearly four months after closing an Illinois facility that made rapid, at-home COVID-19 tests, Abbott Laboratories now plans to restart production there amid a surge in demand for the tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback